Nuclear Medicine (Radio Isotopes) Market – Global Size, Trends, Growth, Segments, Analysis and Forecat to 2027

The global nuclear medicine (Radio Isotopes) market is predicted to reach USD 7.8 billion by 2027, rising at a CAGR of 9.1% in the coming years. Growing patients with cancer and cardiac disorder are the major growth factor for the nuclear medicine market.

With the help of nuclear medicine (radioisotopes) detected by specific types of cameras attached to the monitor and system, nuclear medicine imaging, then offer very accurate images of the area of the body being studied or got infected.

Get a free sample copy in detail of this research report at https://www.vynzresearch.com/healthcare/nuclear-medicine-market/request-sample

Positron Emission Tomography (PET) and Single-photon Emission Computed Tomography (SPECT) is considered as most crucial imaging modalities.

Market Segmentation

The nuclear medicine (Radio Isotopes) market is classified majorly into three sections based on an application which are SPECT, PET, and therapeutic uses.  Based on the disease, the market can be further divided into oncology, cardiology, neurology and others.

By Type

• Diagnostic Nuclear Medicine
  • SPECT Radiopharmaceuticals
  • PET Radiopharmaceuticals
• Therapeutic Nuclear Medicine
  • Alpha Emitters
  • Beta Emitters
• Brachytherapy Isotopes
  • Iodine-125
  • Palladium-103
  • Cesium-131
  • Iridium-192
  • Other Brachytherapy Isotopes

By Application

• SPECT Applications
  • Cardiology
  • Bone Scans
  • Thyroid Applications
  • Pulmonary Scans
  • Others
• PET Applications
  • Oncology
  • Cardiology
  • Neurology
  • Others
• Therapeutic Applications
  • Thyroid Indications
  • Bone Metastasis
  • Lymphoma
  • Endocrine Tumors
  • Other Indications

By End-User

• Hospitals and Diagnostic Centers
• Research Institutes

This report gives a detailed analysis of key trends, the country’s wise government’s rules regulations, key developments, restraints, competitive mapping, and regional/global perspective are analyzed thoroughly. The in-depth insights help in attaining a clear picture of the market development.

Regions Covered

Globally North American market is contributing the largest share of the nuclear medicine market. However, R&D expenditure and government support for the major key players in terms of technologies for radioisotope are from this part of the geography. 

North America

• By Country – U.S., Canada, and Mexico

Europe

• By Country – Germany, U.K., France, Italy, Spain, Russia, and Rest of Europe

Asia-Pacific (APAC)

• By Country – China, Japan, India, South Korea, and Rest of Asia-Pacific

Rest of the World (RoW)

• By Country – Brazil, Saudi Arabia, South Africa, U.A.E., and Other Countries

Ask for Customization according to your requirements at: https://www.vynzresearch.com/healthcare/nuclear-medicine-market/customize-report

Major Key Players in the Global Nuclear Medicine (Radio Isotopes) Market:

• Cardinal Health
• General Electric Company
• Bayer AG
• Curium
• Lantheus Medical Imaging, Inc.
• Medtronic
• Bracco Diagnostic Inc.
• Nordion (Canada) Inc.
• Eczacybaþy-Monrol Nuclear Products
• Advanced Accelerator Applications

Explore more research reports published by VynZ Research:

Global Medical Adhesive Tapes Market – Analysis and Forecast (2021-2027)
https://www.vynzresearch.com/chemicals-materials/medical-adhesive-tapes-market

Global Medical Elastomers Market – Analysis and Forecast (2021-2027)
https://www.vynzresearch.com/chemicals-materials/medical-elastomers-market

Global Medical Lasers Market – Analysis and Forecast (2021-2027)
https://www.vynzresearch.com/healthcare/medical-lasers-market

Global Regenerative Medicine Market – Analysis and Forecast (2021-2027)
https://www.vynzresearch.com/healthcare/regenerative-medicine-market

Contact Information: